Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Spain / NCT06804486
Active, not recruiting Not applicable

Exercise and Physical Activity in Children With Pediatric Acquired Brain Injury

NCT06804486 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-03-01
Last updated
2025-08-24

Condition(s) studied

Acquired Brain Injury

Investigational drug(s) / intervention(s)

ExerciseRecommendation to Deprescribe

Exercise: Exercise and physical-sports activity program

Recommendation to Deprescribe: Recommendation to Deprescribe

Study summary

Exercise and physical activity in children with pediatric acquired brain injury

Eligibility

Sex
ALL
Min age
7 Years
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Be under 18 years of age and present a medical diagnosis of pediatric acquired brain injury. * Have the informed consent completed and signed * Present a state that allows following indications for the practice of exercise and physical-sports activity. Exclusion Criteria: * Have medical comorbidities that contraindicate the safe performance of the program (i.e., cardiac or respiratory instability, uncontrolled seizures). * Have additional disabling conditions, such as cognitive impairment and/or an inability to communicate with the researcher verbally, in writing, or through an emissary. * Non-attendance and/or non-collaboration at 70% of the sessions of the program.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Niño Jesus Hospital Madrid Madrid

More Universidade da Coruña trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06804486 on ClinicalTrials.gov ↗ ← All trials in Spain